At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 72 enrolled
Drug / intervention
NPH insulin plus Complete Insulin Orders +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia
In Brief
A Phase 4 clinical trial evaluating NPH insulin plus Complete Insulin Orders and Complete Insulin Orders for Hyperglycemia. Completed, enrolled 72 participants across 1 site.
Detailed Summary
The objective of this study is to determine the best insulin regimen for hospitalized patients who receive high doses of steroids who have high blood glucose.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperglycemia
CountriesUnited States
CollaboratorsInternational Diabetes Center at Park Nicollet, Sanofi
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2010
First PostedAug 2010
Primary CompletionAug 2012
TodayJul 2026
First PostedAug 18, 2010
Enrollment StartAug 1, 2010
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.9 years ago
Interventions
NPH insulin plus Complete Insulin Ordersdrug
NPH dosed per study-specific algorithm which incorporates total daily dosage of steroid to determine NPH dose. Complete insulin orders include background, meal-time and correction factor.
Complete Insulin Ordersdrug
3-part insulin which includes background, meal-time and correction factor